SENS.A
Latest Trade
2.52USDChange
0.01(+0.40%)Volume
752,488Today's Range
-
2.6452 Week Range
-
3.90As of on the NYSE MKT LLC ∙ Minimum 15 minute delay
Previous Close | 2.51 |
|---|---|
Open | 2.64 |
Volume | 752,488 |
3M AVG Volume | 560.18 |
Today's High | 2.64 |
Today's Low | 2.43 |
52 Week High | 3.90 |
52 Week Low | 0.35 |
Shares Out (MIL) | 284.24 |
Market Cap (MIL) | 954.77 |
Forward P/E | -6.48 |
Dividend (Yield %) | -- |
Senseonics Holdings Announces $50.0 Million Bought Deal Offering Of Common Stock
Senseonics Holdings Sees FY Revenue $12 Million To $15 Million
Senseonics Holdings Reports Q3 2020 Financial Results
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.
Industry
Medical Equipment & Supplies
Contact Info
20451 Seneca Meadows Pkwy
GERMANTOWN, MD
20876-7005
United States
+1.301.5157260
https://www.senseonics.com/Executive Leadership
Stephen P. DeFalco
Independent Chairman of the Board
Timothy T. Goodnow
President, Chief Executive Officer, Director
Nick B.. Tressler
Chief Financial Officer, Treasurer, Secretary
Mukul Jain
Chief Operating Officer
Mirasol Panlilio
Vice President and General Manager - Global Commercial Operations
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 95.32 |
Price To Book (MRQ) | -- |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | -- |
LT Debt To Equity (MRQ) | -- |
Return on Investment (TTM) | -121.92 |
Return on Equity (TTM) | -103.40 |
* SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS
* SENSEONICS - DUE TO COVID-19, FINANCING ACTIVITIES AND COST-REDUCTION INITIATIVES TAKEN, INCLUDING SIGNIFICANT HEADCOUNT REDUCTIONS
* SENSEONICS EVERSENSE® SENSOR RECEIVES MRI CONDITIONAL APPROVAL IN EUROPE Source text for Eikon: Further company coverage:
* SENSEONICS HOLDINGS INC - ON APRIL 22, UNIT RECEIVED $5.8 MILLION IN LOAN FUNDING FROM PAYCHECK PROTECTION PROGRAM Source: (https://bit.ly/2W1j7wF) Further company coverage:
* SENSEONICS ENTERS INTO NEW CREDIT FACILITIES WITH CERTAIN FUNDS MANAGED BY HIGHBRIDGE CAPITAL MANAGEMENT, LLC
* SENSEONICS HOLDINGS INC - SUSPENDING COMMERCIAL SALES IN UNITED STATES OF ITS 90-DAY EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM
* SENSEONICS HOLDINGS INC - ON MAR 22, CO & SOLAR CAPITAL LTD TERMINATED THAT CERTAIN LOAN AND SECURITY AGREEMENT, DATED AS OF JULY 16, 2019
* SENSEONICS EXPLORING STRATEGIC OPTIONS TO ENHANCE STAKEHOLDER VALUE
* SENSEONICS ANNOUNCES THE FDA APPROVAL TO CONTINUE THE PROMISE SENSOR CLINICAL STUDY IN AN EXTENDED COHORT TO 365 DAYS TO GATHER FEASIBILITY DATA Source text for Eikon: Further company coverage:
* SENSEONICS REPORTS AT ATTD GLYCEMIC OUTCOMES ACROSS ADULT AGE RANGES WITH REAL-WORLD EVERSENSE CGM USE Source text for Eikon: Further company coverage:
* SENSEONICS ANNOUNCES PARTNERSHIP WITH COMPANION MEDICAL Source text for Eikon: Further company coverage:
* SENSEONICS ANNOUNCES EXTENSION OF DISTRIBUTION AGREEMENT WITH ROCHE DIABETES CARE
* SENSEONICS - ON DEC. 20, UNIT ENTERED INTO AMENDMENT WITH ROCHE TO THEIR MAY 23, 2016 DISTRIBUTION AGREEMENT TO EXTEND AGREEMENT TERM UNTIL JAN. 31, 2019
* SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* SENSEONICS HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING Source text: [https://bit.ly/2qJDrDR] Further company coverage:
* SENSEONICS HOLDINGS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: [https://bit.ly/2GDV1lV] Further company coverage:
* SENSEONICS ANNOUNCES FAVORABLE OUTCOME OF FDA ADVISORY COMMITTEE ON THE EVERSENSE SYSTEM
* SENSEONICS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
* SENSEONICS ANNOUNCES PROPOSED CONVERTIBLE SENIOR SUBORDINATED NOTES OFFERING
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.